Literature DB >> 19200699

Bioinformatics analyses of the mannose-binding lectins from Polygonatum cyrtonema, Ophiopogon japonicus and Liparis noversa with antiproliferative and apoptosis-inducing activities.

Bo Liu1, Hao Peng, Qing Yao, Jing Li, Els Van Damme, Jan Balzarini, Jin-ku Bao.   

Abstract

In the present study, three typical monocot mannose-binding lectins (e.g., Polygonatum cyrtonema lectin [PCL], Ophiopogon japonicus lectin [OJL] and Liparis noversa lectin [LNL]), were reported to possess a similar tertiary structure with three mannose-binding sites and a close phylogenetic relationship. Subsequently, these lectins were found to bear remarkable inhibitory effects on the growth of MCF-7 cells. Further experiments confirmed that there is a link among the hemagglutinating activity, antiproliferative activity and mannose-binding activity. In addition, these lectins were shown to induce MCF-7 cell apoptosis and caspase was found to be involved in this apoptotic pathway. In conclusion, these findings demonstrate that the different antiproliferative effects may be due to the conserved motifs of mannose-binding sites. Furthermore, our results demonstrate that these lectins induce apoptosis in MCF-7 cells via a caspase-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19200699     DOI: 10.1016/j.phymed.2008.12.010

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  9 in total

Review 1.  Could plant lectins become promising anti-tumour drugs for causing autophagic cell death?

Authors:  Z Liu; Y Luo; T-T Zhou; W-Z Zhang
Journal:  Cell Prolif       Date:  2013-08-24       Impact factor: 6.831

2.  Molecular modeling, docking and dynamics simulations of GNA-related lectins for potential prevention of influenza virus (H1N1).

Authors:  Huai-long Xu; Chun-yang Li; Xue-mei He; Ke-qin Niu; Hao Peng; Wen-wen Li; Cheng-cheng Zhou; Jin-ku Bao
Journal:  J Mol Model       Date:  2011-03-29       Impact factor: 1.810

3.  Purification, characterization and molecular cloning of a monocot mannose-binding lectin from Remusatia vivipara with nematicidal activity.

Authors:  Ganapati G Bhat; Kartika N Shetty; Nagaraja N Nagre; Vivek V Neekhra; S Lingaraju; Ramesh S Bhat; Shashikala R Inamdar; K Suguna; Bale M Swamy
Journal:  Glycoconj J       Date:  2010-03-06       Impact factor: 2.916

Review 4.  Anti-tumor and anti-viral activities of Galanthus nivalis agglutinin (GNA)-related lectins.

Authors:  Lei Wu; Jin-Ku Bao
Journal:  Glycoconj J       Date:  2012-08-15       Impact factor: 2.916

Review 5.  Plant lectins, from ancient sugar-binding proteins to emerging anti-cancer drugs in apoptosis and autophagy.

Authors:  Q-L Jiang; S Zhang; M Tian; S-Y Zhang; T Xie; D-Y Chen; Y-J Chen; J He; J Liu; L Ouyang; X Jiang
Journal:  Cell Prolif       Date:  2014-12-09       Impact factor: 6.831

6.  Molecular mechanisms of Lycoris aurea agglutinin-induced apoptosis and G2 /M cell cycle arrest in human lung adenocarcinoma A549 cells, both in vitro and in vivo.

Authors:  C-Y Li; Y Wang; H-L Wang; Z Shi; N An; Y-X Liu; Y Liu; J Zhang; J-K Bao; S-P Deng
Journal:  Cell Prolif       Date:  2013-06       Impact factor: 6.831

Review 7.  Plant-Derived Lectins as Potential Cancer Therapeutics and Diagnostic Tools.

Authors:  Milena Mazalovska; J Calvin Kouokam
Journal:  Biomed Res Int       Date:  2020-05-15       Impact factor: 3.411

8.  Characterization of the hypersensitive response-like cell death phenomenon induced by targeting antiviral lectin griffithsin to the secretory pathway.

Authors:  Bo Min Kim; Hester Catharina Therese Lotter-Stark; Edward P Rybicki; Rachel K Chikwamba; Kenneth E Palmer
Journal:  Plant Biotechnol J       Date:  2018-05-02       Impact factor: 9.803

9.  Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities.

Authors:  Hao Peng; Hui Lv; Ying Wang; Yan-hong Liu; Chun-yang Li; Liang Meng; Fang Chen; Jin-ku Bao
Journal:  Peptides       Date:  2009-07-03       Impact factor: 3.750

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.